Haemonetics Corp. (HAE) Tops Q3 EPS by 3c; Reaffirms Outlook
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $91.34 +4.72%
Financial Fact:
Provision for income taxes: 3M
Today's EPS Names:
ITG, MTEX, NSYS, More
Financial Fact:
Provision for income taxes: 3M
Today's EPS Names:
ITG, MTEX, NSYS, More
Join SI Premium – FREE
Haemonetics Corp. (NYSE: HAE) reported Q3 EPS of $0.50, $0.03 better than the analyst estimate of $0.47. Revenue for the quarter came in at $247.4 million versus the consensus estimate of $251.93 million.
Reaffirmed FY13 and FY14 guidance.
For earnings history and earnings-related data on Haemonetics Corp. (HAE) click here.
Reaffirmed FY13 and FY14 guidance.
For earnings history and earnings-related data on Haemonetics Corp. (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
- Faraday Future stockholders approve $25M private placement proposal
- CAE, Inc. (CAE) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
